St. Jude Medical to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference
May 25 2011 - 8:00AM
Business Wire
St. Jude Medical, Inc. (NYSE:STJ) will present at the Goldman
Sachs 32nd Annual Global Healthcare Conference on Thursday, June 9,
in Rancho Palos Verdes, California. John Heinmiller, executive vice
president and chief financial officer, will address the conference
at 10:40 a.m. PDT. The presentation will also be Web cast live at
www.sjm.com.
About St. Jude MedicalSt. Jude Medical, Inc. develops
medical technology and services that focus on putting more control
into the hands of those who treat cardiac, neurological and chronic
pain patients worldwide. The company is dedicated to advancing the
practice of medicine by reducing risk wherever possible and
contributing to successful outcomes for every patient. St. Jude
Medical is headquartered in St. Paul, Minn. and has four major
focus areas that include cardiac rhythm management, atrial
fibrillation, cardiovascular and neuromodulation. For more
information, please visit www.sjm.com.
Forward-Looking StatementsThis news release contains
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995 that involve risks and
uncertainties. Such forward-looking statements include the
expectations, plans and prospects for the Company, including
potential clinical successes, anticipated regulatory approvals and
future product launches, and projected revenues, margins, earnings
and market shares. The statements made by the Company are based
upon management's current expectations and are subject to certain
risks and uncertainties that could cause actual results to differ
materially from those described in the forward-looking statements.
These risks and uncertainties include market conditions and other
factors beyond the Company's control and the risk factors and other
cautionary statements described in the Company's filings with the
SEC, including those described in the Risk Factors and Cautionary
Statements sections of the Company's Annual Report on Form 10-K for
the fiscal year ended January 1, 2011 and Quarterly Report on Form
10-Q for the fiscal quarter ended April 2, 2011. The Company does
not intend to update these statements and undertakes no duty to any
person to provide any such update under any circumstance.
SJM (NYSE:STJ)
Historical Stock Chart
From Jun 2024 to Jul 2024
SJM (NYSE:STJ)
Historical Stock Chart
From Jul 2023 to Jul 2024